How to Use LIPOLAB | Best Dosage, Safety & Results Guide

Safe use of Lipo Lab lipolysis injections must be performed by professional medical personnel. Do not inject yourself to prevent infection. The clinical standard dosage is 0.2-0.5ml per point, with a spacing of 1-1.5cm between points. A single abdominal dose is approximately 1-2 (10ml/). For best fat reduction results, it is recommended to complete 3-5 full courses of treatment, with each interval lasting 10-15 days. Slight local swelling and bruising in the early post-operative period are normal reactions. Significant fat reduction and circumference reduction can usually be observed within 2-3 weeks. Pregnant women, lactating women, and patients with cardiovascular diseases are strictly prohibited from using it.

Best Dosage

The maximum single total body dose for Lipo Lab is set at 50ml (equivalent to 5 standard 10ml ). For small facial areas, the single point injection volume is 0.1-0.2ml, with a entry point spacing of 1.0-1.5cm, and the single local total volume controlled at 10-20ml; For trunk areas, the single point injection volume is 0.4-0.5ml, with a entry point spacing of 1.5-2.0cm, and a single total volume of 30-50ml. The needs to be physically positioned in the subcutaneous fat layer at a depth of 6-13mm. Regular treatment requires 3-5 injections, with each physical interval lasting 10-15 days.

Different Body Parts

The thickness of the subcutaneous fat pad anterior to the platysma muscle is usually between 1.5 and 3.0 cm. For the submandibular area, use calipers to measure fat thickness before injection. It must be greater than 10 mm to meet the injection standard. Use a 30G, 13 mm long fine, inserting it subcutaneously at a 45-degree angle. The grid point spacing on the lower edge of the face is set at 1.0 cm. The amount of liquid injected at each point is controlled at 0.15 to 0.2 milliliters. The total amount administered in a single session does not exceed 20 milliliters, which is equivalent to two standard stock solutions. After the liquid enters the fat layer, deoxycholic acid sodium will act within 5 minutes to destroy cell membranes. The submandibular anatomical area has a dense microvascular network, so the injection speed needs to be slowed to 0.05 milliliters per second. The fat layer on the outer side of the triceps brachii is relatively thin and distributed in strips. In a naturally relaxed state, the fat fold thickness measured by pinching the local skin needs to reach more than 15 mm. Use a water-based marker to draw a grid pattern about 4 to 6 cm wide. The entry point spacing is extended outwards to 1.2 to 1.5 cm. The injection volume is adjusted to 0.2 to 0.3 milliliters per point. The total single dose for both arms is controlled between 20 and 30 milliliters. The is inserted perpendicularly to the skin surface to a depth of about 6 to 8 millimeters. If the operation touches the underlying muscle fibers, the tip must be retracted by 2 millimeters before injecting.

• angle: 90 degrees vertical or 60 degrees inclined into the skin
• Injection retention: After injecting the liquid, the remains in place for 3 seconds before being removed
• Leakage prevention: After withdrawal, apply physical pressure with sterile dry gauze for 15 seconds
• Point limit: No more than 15 injection points per arm

The abdominal wall is the area with the highest density of free fatty acid accumulation, and the thickness of the subcutaneous fat layer often exceeds 3.5 cm. Taking the patient’s navel as the center, divide it outwards into 5×5 cm grid blocks. Avoid the annular area with a radius of 5 cm around the navel and the location of the linea alba. The entry point spacing is set at 1.5 to 2.0 cm to ensure that the internal drug diffusion radius does not overlap. The single point injection volume for the abdomen is increased to 0.4 to 0.5 milliliters. The total single dose can reach the upper limit of 30 to 50 milliliters. A 27G, 13 mm long is used, inserted perpendicularly at 90 degrees completely into the subcutaneous fat layer. The subcutaneous tissue of the abdomen is relatively loose, and it has the highest physiological tolerance for a 50 milliliter drug volume. The fat in the lateral waist is mostly block-shaped, separated by connective tissue capsules. The local pinch test thickness is usually between 2.5 and 4.0 cm. For lateral waist operations, the entry point spacing is maintained at 1.5 cm. To cover deep fat clusters, some points use a 25 mm long blunt, injecting the liquid in a fan shape at 15 mm subcutaneously. The inner thigh skin is thinner and rich in saphenous vein branches. The operation avoids the middle and lower third segments of the inner thigh. The injection area is concentrated in the upper third segment near the groin. The spacing is 1.5 cm, the single point injection is 0.3 ml, and the total dose for both inner thighs does not exceed 30 ml. The fat density at the outer thigh saddlebag position is higher, often accompanied by the appearance of cellulite. The entry point spacing is shortened to 1.2 cm, and 0.4 ml is injected per point. The needs to be inserted vertically subcutaneously to a depth of 10 to 13 mm. After injection, a 5-minute manual massage is supplemented to help 1000mg of PPC molecules penetrate high-density fat clusters. The crescent-shaped fat accumulation area below the buttocks has a complex network of supporting ligaments. The grid points need to be horizontally arranged in a straight line 1 cm below the gluteal fold. The dosage for each point is 0.3 ml, and the depth is limited to within 8 mm. The North American Academy of Cosmetic Surgery provides a set of numerical standardized dosing guidelines.

The parameters in the table need to be fine-tuned by 10% based on the subcutaneous water content of the patient. For dry fat tissue with water content below 50%, the single point injection volume is lowered to the lower limit of the standard value. Water-filled tissue can dilute PPC concentration faster. Operation can be performed when the pinch-measured fat thickness is greater than 20 millimeters. Due to the thicker dermal layer on the back, the must completely penetrate the dermis to reach the subcutaneous fat layer at 8 to 10 millimeters. The spacing is set at 1.5 centimeters, and 0.25 milliliters is injected per point.

• Patients with a basic body fat rate (BMI) greater than 32 need to intervene with weight control first
• Stop abdominal area injection operations 3 days before the female physiological period
• Marker pens must use medical alcohol-erasable dye
• Hair in the injection area must be shaved and disinfected 48 hours in advance
• Rinse the skin surface with normal saline at room temperature to remove residual grease

The small fat clusters on the inner side of the knee often cause physical friction when the legs are brought together. The fat layer in the target operating area is extremely thin and close to the joint capsule. The thickness measured by calipers must reach 12 mm before injection can be performed. A 32G extra-fine is selected, and the insertion depth is strictly controlled between 5 and 6 millimeters. The single point injection volume is reduced to 0.1 milliliters, and the total dosage for both knees must not exceed 10 milliliters. The subcutaneous fat distribution behind the gastrocnemius muscle of the calf is uneven and often tightly adhered to muscle tissue. Before the operation, the patient needs to stand on tiptoes to contract the calf muscles, thereby accurately locating the free subcutaneous fat layer. The spacing is maintained at 1.5 cm, and the single calf injection volume is controlled within 15 ml. Controlling the dosage can avoid compression of the posterior tibial nerve bundle. If a total dose of 50 milliliters is used in the first course of treatment, the total dose in the second course needs to be reduced by 15% to 20% based on the fat thickness reduction measured by B-ultrasound. The horizontal diffusion radius of the liquid under the skin within 48 hours is approximately 0.8 to 1.2 cm. Grid point distribution according to the drawing can prevent asymmetric depressions in adjacent areas. During the injection process, sodium chloride solution should be available on the operating table. If more than 0.1 ml of liquid leaks from the skin surface, it should be wiped with saline to prevent epidermal burning and peeling caused by high-concentration DC components. After local injection, apply ice for 15 minutes to constrict capillaries, reducing acute edema caused by exudation of tissue fluid.

• Chin area care: Wear a chin elastic band for 4 to 6 hours daily
• Arm area care: Avoid lifting objects weighing more than 5 kg within one week after surgery
• Abdominal area care: Wear a medical shaping garment with level 1 pressure for 2 weeks
• Leg area care: Wear 20-30mmHg gradient varicose vein stockings during the day
• Back area care: Sleep on your side to reduce pressure on the back

The peak pharmacological effect occurs 72 hours after injection. The lymphatic system phagocytoses lipid droplet residues through macrophages within the subsequent 14 days. Daily water intake must be forcibly increased to more than 2.5 liters. Water intake maintains the kidney’s filtration pressure, accelerating the excretion of metabolites after triglyceride hydrolysis through urine.

Control & Angle

The total thickness of the epidermis and dermis of human skin is usually between 1.5 and 3.0 millimeters. Lipo Lab’s pharmacological target area is the deep subcutaneous fat cell layer. The operator must ensure that the tip penetrates the dermal reticular layer and accurately remains at a depth of 6 to 13 millimeters from the skin surface. The mandatory standard for physical assessment before injection is subcutaneous pinching. The operator needs to pinch the skin tissue in the target area with the thumb and index finger, and use medical calipers to measure the folded thickness. The folded thickness must reach 20 millimeters to meet the minimum safe injection threshold. When the caliper reading is below 15 millimeters, the physical space of the fat layer is insufficient to accommodate a single point drug volume of 0.2 milliliters. If deoxycholic acid (DC) is released in the subdermal vascular plexus (depth of about 3-4 millimeters), it will cause severe capillary spasms. To avoid accidental injection of the liquid into non-fat tissues, international medical aesthetics guidelines have established physical parameters for insertion angles at different caliper readings.

• Pinch thickness 15-20mm: choose 8mm, insert at 45 degree angle
• Pinch thickness 20-30mm: choose 13mm, insert at 60 degree angle
• Pinch thickness 30-40mm: choose 13mm, insert at 90 degree angle
• Pinch thickness >40mm: choose 13mm, insert at 90 degree angle deeply and press down skin by 2mm

90-degree vertical insertion is mainly used for the abdominal wall, lateral waist, and outer thigh areas. The operator holds a 10ml, with the forming an absolute right angle with the patient’s body surface. When the penetrates the skin, a constant physical thrust of 3 Newtons must be maintained to fully embed it in the skin. Along the vertical insertion path, a slight sensation of resistance breakthrough will be felt when the penetrates the bottom of the dermal layer (about 3 mm deep). At this point, the tip has entered the loose superficial subcutaneous fat layer and needs to be advanced an additional 10 mm to reach the deep fat layer rich in large fat cells. When the target area is the double chin or the back of the upper arm, the anatomical fat thickness is significantly reduced. At the submandibular margin with a pinch thickness of only 18 mm, using a 13 mm for a 90-degree injection will cause the tip to touch and penetrate the platysma fascia at the bottom of the fat layer. To reduce the vertical penetration depth, the injection angle must be tilted towards the skin surface to 45 degrees. According to geometric trigonometric function conversion, the actual vertical penetration depth of a 13 mm tip at a 45-degree tilt is precisely 9.1 mm. The liquid is precisely released into the geometric center of the submandibular fat pad. The 60-degree insertion method is suitable for curved areas such as the inner thigh or groin. The tangent of the entry point forms a 60-degree angle with the tube, and the actual vertical depth of a 13 mm is reduced to 11.2 mm. A small deviation in the operating angle can result in quantifiable depth displacement. Every 5-degree angular deviation of the hand holding the will result in a physical depth error of more than 1.1 mm.

• 30 degree angle injection: actual depth 6.5 mm (remains in the superficial fascia layer)
• 45 degree angle injection: actual depth 9.1 mm (matches facial/arm fat pad)
• 60 degree angle injection: actual depth 11.2 mm (matches superficial inner thigh)
• 90 degree angle injection: actual depth 13.0 mm (matches deep abdominal fat)

The standard requires the injection speed to be controlled at 0.05 to 0.1 milliliters per second. Thumb pressing the plunger needs to maintain a uniform physical pressure of 0.5 Newtons to prevent the liquid from forming a high-pressure jet at the tip. Injecting more than 0.2 milliliters of liquid instantaneously will create an instantaneous hydraulic pressure greater than 50 mmHg in the fat cell spaces. The sudden increase in tissue pressure will force PPC molecules to flow backward along the injection track to the dermis, causing local chemical skin burns. After a single point liquid injection is completed, the hand holding the must remain absolutely still at the original angle and depth for 3 to 5 seconds. The internal pause allows the residual pressure inside the and the subcutaneous tissue fluid pressure to reach physical equilibrium. The speed of withdrawal needs to be increased to 20 millimeters per second, quickly and cleanly exiting the skin surface. Slow withdrawal can cause a small amount of Lipo Lab stock solution (approximately 0.01 ml) remaining on the inner wall of the to be smeared on the penetrated dermal wound, causing inflammatory erythema that is difficult to subside within 14 days after surgery. The entire injection process relies heavily on the operator’s tactile perception of tissue reaction force. Anatomical structures at different depths produce distinctly different physical resistance values for 30G.

• Epidermal penetration stage: Resistance peak 2.0 Newtons (accompanied by a slight barrier breakthrough sensation)
• Through the dermal reticular layer: Continuous resistance 1.5 Newtons (similar to the toughness of piercing rubber)
• Submerging into superficial fat: Resistance drops sharply to 0.2 Newtons (similar to the hollowness of sponge gaps)
• Touching muscle fascia: Resistance rises back to 1.8 Newtons (a firm and elastic contractile sensation)

If during insertion, the resistance value suddenly drops below 0.1 Newtons and is accompanied by obvious pain feedback from the patient, the tip may have slipped into a tiny venous lumen 15 mm under the skin. The operator needs to stop the injection, retract the 3 mm along the original path, and observe if there is blood aspiration in the. In the standing position, due to gravity (9.8 m/s²), the abdominal fat pad undergoes downward physical displacement. The injection points marked in the sitting position will shift upwards by approximately 2 to 3 cm to the thickest part of the actual fat layer when the patient lies flat. All parameters regarding angle and depth must be strictly followed when the patient is in the supine or lateral position. The supine position causes the fat layer to spread evenly to both sides, and local epidermal tension decreases by 20%. When pinching and lifting the fatty tissue, the force distribution is more even, preventing the from transversely penetrating the edges of the free fat lobules. For individuals with a large body mass index (BMI) between 30 and 35, the abdominal wall typically has a double-layered fat structure. The superficial fat layer is about 15 mm thick, and the deep fat layer can be up to 30 mm thick. The superficial and deep layers are physically separated by a 0.5 mm thick Scarpa’s fascia. Breaking through the internal fascial barrier requires slightly increased insertion force. When a 13 mm is inserted vertically at 90 degrees, if it is obstructed at a depth of 15 mm, downward pressure needs to be applied to create a 2 mm indentation in the skin. This action ensures the tip penetrates the fascia into the deep fat layer, achieving a full 0.5 ml dose distribution in a single session. The asymmetrical anatomical features of the human face require different parameters for the left and right sides. The anterior prominence of the left side of the mandible is usually 1.2 mm more than the right side. When injecting on the left side of the double chin, the angle can be maintained at 45 degrees; on the relatively flat right side, the angle needs to be lowered to 40 degrees to match the asymmetrical fat distribution volume. The illuminance of the shadowless lamp needs to reach 50,000 lux, and the color temperature should be maintained at 4500K to eliminate physical shadows in the injection area. High-brightness illumination helps the operator accurately identify the 0.5 mm skin erythema diffusion range that occurs after epidermal puncture.

Treatment Course & Time Interval

The biochemical reaction cycle of Lipo Lab is jointly determined by the half-life of deoxycholic acid (DC) and the body’s lymphatic metabolic rate. After 1000mg of PPC molecules are injected into the subcutaneous fat layer, the first 72 hours are the acute lipid dissolution phase. Fat cell membranes rupture within the first 5 minutes of contact with the drug, releasing intracellular stored triglycerides into the free interstitial spaces. Free fatty acids need to be degraded a second time through the phagocytosis of macrophages. From day 4 to day 7, more than 500 macrophages gather in each cubic millimeter of local tissue. This phagocytic process is accompanied by microvascular dilation, and the local surface temperature of the injected area will be 0.5 to 1.2 degrees Celsius higher than the surrounding normal skin, and the physical swelling volume will reach its peak. The window for the lymphatic system to take over metabolite transport is between day 8 and day 14 after injection. The decomposed lipid droplet residues enter the microlymphatic vessels as micron-sized particles. For patients with a basal metabolic rate (BMR) above 1500 kcal, the lymphatic return speed is 1.5 to 2.0 milliliters per minute, enabling the degradation of fat from the initial 50 ml stock solution through the liver within 14 days. In the same anatomical area, the operator must wait at least 10 natural days for the interstitial pressure in the local edematous tissue to drop below 15 mmHg. Injecting the liquid again too early into an incompletely excreted fat layer can lead to increased capillary fragility and widespread subcutaneous hemorrhage. Measuring soft free fat with ultrasound echoes below -60HU, after 3 administrations at 14-day intervals, its physical thickness can be reduced by 10 to 15 mm. For hard, honeycomb-like fat with hyperplastic fibrous septa, 5 interventions are required to achieve the same thickness reduction. As the volume of subcutaneous fat tissue decreases, the density of the local microvascular network will relatively increase. In the 3rd injection cycle, the same volume of stock solution contacts 25% more capillaries, and the drug is carried away by the systemic blood circulation faster, weakening the local targeted dissolution ability. For different intervention frequencies, the operating guidelines define clear dosing ratio conversions:

• Initial dosage: 100% of the safe dose limit to establish initial lipid dissolution concentration
• Second dose: If caliper measurement shows a 20% reduction in thickness, the dose is reduced to 85% of the first dose
• Third dose: Based on the presence of palpable nodules, the dose is reduced to 70% of the first dose
• Fourth to fifth doses: Only for residual fat clusters thicker than 15 millimeters, single point injection less than 0.2 milliliters

To maintain the balance between drug concentration in the blood and liver decomposition pressure, individuals with a BMI between 25 and 30 are suitable for the shortest 10-day interval plan. These patients have a wide total body fat area, and liver transaminases often fluctuate between 30 to 40 U/L at the upper limit of normal, so they can withstand high-frequency lipid degradation pressure.

For patients over 45 years old, due to decreased basal metabolism, fibroblast regeneration capacity is reduced by 30%. The treatment interval for this group must be extended to 15 to 21 days to avoid local skin laxity caused by delayed collagen synthesis.

The treatment course is also constrained by the patient’s excretion efficiency. The 1000mg large molecule PPC ultimately needs to be metabolized and broken down into water-soluble byproducts and excreted through urine. Within a complete treatment cycle, for patients with a single-day urine output of less than 1.5 liters, the serum half-life of fatty acid metabolites will be extended from the normal 48 hours to more than 72 hours. From day 1 to day 14 after each injection, daily water intake must be forcibly increased to 2.5 to 3.0 liters. The physical osmotic pressure of pure water can promote extracellular fluid flow, accelerating the flushing of waste lipid droplets retained 6 to 13 millimeters under the skin into the surrounding microlymphatic capillary network. Continuous administration exceeding 5 treatment courses can induce the body’s defensive reaction. High-concentration DC stimulation for more than 50 days can lead to irreversible excessive proliferation of fibroblasts in the subcutaneous reticular dermis. The originally loose fat layer will be replaced by fibrous scar tissue with a thickness exceeding 3 millimeters, making the local touch feel as stiff as rubber. Before entering each independent treatment cycle, the patient’s physiological indicators must be quantitatively screened:

• Liver function indicators (ALT/AST): Must be below 45 U/L before injection, postpone treatment if exceeded
• Prothrombin time (PT): Maintain in the range of 11 to 13 seconds to avoid deep hematoma during injection
• Glycated hemoglobin (HbA1c): Controlled within 6.5%, high blood sugar levels hinder lymphatic excretion
• Local surface temperature measurement: Confirm that the temperature of the injection area does not differ by more than 0.2 degrees Celsius from the surrounding normal tissue

Liposuction surgery under general anesthesia only shows final stable shape 6 months after surgery, while non-surgical dissolution shortens the timeline of morphological changes. On the 45th day after completing 3 standard injections, the subcutaneous fat echo area under B-ultrasound was reduced by an average of 22.4% compared to the baseline value, reaching the physiological limit of non-surgical fat reduction.

Hormone level changes during the menstrual cycle in female patients cause significant interference. Progesterone secretion increases during the luteal phase, and interstitial fluid retention in tissue increases by approximately 15%. Treatment plans must avoid 3 to 5 days before menstruation to prevent overlapping physiological edema from masking true fat metabolism data.

8 AM to 10 AM is the peak period for human cortisol secretion, during which the sensitivity of subcutaneous nerve endings to physical pain caused by insertion is 18% lower compared to 4 PM. Arranging a single 50 ml high-dose treatment during this period can effectively reduce the incidence of vasovagal syncope in patients. More than 50 punctures can leave micro-wounds on the skin surface that are difficult to see with the naked eye. During the interval between each administration, the stratum corneum will complete physical closure within 48 hours. If the local area comes into contact with skincare products containing fragrances or swimming pool water with chlorine levels exceeding 1.0 ppm before the physical wound is completely epithelialized, contact dermatitis is highly likely to be induced. As the treatment enters its final stage, the local fat accumulation thickness has dropped to a critical line of 10 millimeters. For the last administration, the operator needs to replace it with an extremely short, 32G and 4 millimeters long. At this stage, only a trace amount of 0.05 milliliters needs to be spread in the shallowest layer of the residual fat pad (about 5 millimeters deep) to complete the physical repair of the tissue surface flatness.

Safety

The total dose per injection should not exceed 3 (30ml, corresponding to 3000mg PPC). The must be 30G or 32G, inserted vertically at 90 degrees into the subcutaneous fat layer at a depth of 6mm-13mm. Deviation to the dermis (< 4mm) can cause local skin ulceration. The 99.8% purity PPC in the product is extracted from soybeans, so it cannot be used by individuals with soy allergies. Dissolved free fatty acids need to be processed by the liver and kidney system within 21-28 days. During this period, 2.5-3 liters of water should be consumed daily. The interval between two treatments must be at least 4 weeks.

Physiological Response & Time

After the liquid is injected into the subcutaneous fat layer at a depth of 6mm to 13mm, deoxycholic acid (DC) immediately chemically binds to the bimolecular layer of fat cells. Cell membrane rupture initiates within 3 to 5 minutes after injection, releasing internal stored triglycerides. The pH value of the local tissue will temporarily drop from the normal 7.4 to around 6.8, causing a slight sour and swelling sensation. Local pH changes activate subcutaneous receptors, and patients will experience 3/10 dull pain within the subsequent 15 to 30 minutes. The massive release of histamine leads to increased capillary permeability, and the injection area develops visible erythema and mild edema within 2 hours. Within 24 to 48 hours after injection, local swelling reaches its physical peak, and the circumference of the abdomen or chin area temporarily increases by 1.5 cm to 3 cm. The skin surface temperature will be 1.2°C to 1.5°C higher than the surrounding normal tissue.

• Tissue feel: presents a physically tight, water-filled sponge feel
• Pressure pain level: pain reaches 5/10 when 2 pounds of vertical pressure is applied
• Skin color change: the area covered by the injection grid shows a uniform light red hue
• Local heating: infrared thermometer shows surface temperature rises to about 37.8°C

In addition to edema, the 30G or 32G inevitably severs some microvessels with diameters of 0.05mm to 0.1mm when penetrating the reticular dermis. After blood oozes into the subcutaneous space, hemoglobin in red blood cells begins to degrade. 72 hours after injection, purplish-red bruising with a diameter of 1 cm to 3 cm appears on the skin surface. Macrophages migrate in large numbers to the damaged fat lobule area on day 3, initiating the biological process of phagocytosing free lipids. The immune clearance process enters its most efficient operational phase from day 7 to day 10. Billions of dead cell fragments are packaged into the microlymphatic capillary network every day. Accompanied by the aggregation of a large number of macrophages and lipid emulsification, aseptic inflammatory nodules form at a subcutaneous depth of 8mm to 12mm. When patients touch the injection area on day 5, they will feel multiple hard lumps with a diameter of 0.5 cm to 1.5 cm. Tiny lipid aggregate particles are formed by phosphatidylcholine (PPC) encapsulating triglycerides.

• Physical form: smooth pea-shaped or peanut-shaped
• Free state: can slide slightly within 1 cm under the skin
• Texture hardness: possesses the physical feel of a medical silicone implant
• Regression cycle: takes an average of 14 to 21 days to soften on its own

After entering week 2, excess water in the interstitial tissue is expelled through the lymphatic system at a rate of 15 to 20 milliliters per day. The physical swelling of the injected area drops sharply, the erythema completely subsides, and the surface skin temperature returns to the normal baseline of 36.5°C. The purplish-red bruising completes its chemical color conversion at this stage. The metabolism of bilirubin and biliverdin causes the edges of the patch to turn dark yellow or light green on day 10. By around day 14, deposited hemosiderin is completely cleared, and the epidermis regains its original physiological skin tone. The emptied fat lobule space needs new collagen networks to fill and tighten. Fibroblasts are activated in large numbers on day 15, secreting type I and type III collagen fibers. The thickness of the damaged dermal reticular layer increases by 15% to 20% in the next 4 weeks, preventing local skin laxity. Emulsified fatty acid particles enter the thoracic duct along the lymphatic vessel network at a flow rate of 2 to 4 millimeters per minute.

For lipid metabolites produced by a single injection of 30ml Lipo Lab stock solution, the adult liver requires a physiological cycle of 21 to 28 days to completely process them. During this period, blood triglyceride levels will briefly rise by 5% to 8%, but remain within the normal blood test standards.

• Circumference reduction: average reduction of 1.5 cm to 2.5 cm in anatomical circumference on day 28
• Nodule degradation: subcutaneous tissue becomes smooth again, physical sensation of lumps completely disappears
• Structural thickness: ultrasound examination shows an average fat layer thinning of 3 mm to 5 mm
• Tissue elasticity: stretch and rebound test shows a 10% increase in local skin firmness

By day 30, the cellular-level microscopic reactions triggered by the first injection come to an end. Inflammatory factor levels in the recipient tissue return to a baseline state of 0. Only after a complete 4-week metabolic cycle has ended does the same anatomical area become biologically ready to receive a second 3000mg dose.

Inapplicable Situations

Lipo Lab’s pharmacology is designed for localized subcutaneous fat accumulation, and the maximum injection limit for a single treatment is strictly limited to 30ml or 3000mg of PPC. When the patient’s BMI (Body Mass Index) exceeds 30, the total amount of free fat in the body far exceeds the biochemical processing limit of this dose. Obesity levels with a BMI of 30 or even higher are usually accompanied by intra-abdominal visceral fat thickness exceeding 5 cm. Deoxycholic acid (DC) cannot penetrate the linea alba to dissolve visceral fat in the abdominal cavity. Injecting 30ml of the stock solution into these individuals usually results in a visible circumference change of less than 0.5 cm.

3000mg of targeted dose produces minimal biochemical reaction in the face of over 25 kg of excess systemic fat.

Excessive initial body fat percentage can reduce the visual feedback of a single treatment. The operating standard requires the patient’s BMI to be maintained within the healthy range of 18.5 to 25, at most extended to the overweight threshold of 29.9. Subjects exceeding this value need to lose at least 10% to 15% of weight through caloric deficit first. The 30ml of liquid injected will destroy approximately 5 to 8 million fat cells within 72 hours. The released billions of free triglyceride particles rely 100% on the liver’s β-oxidation pathway and the kidney’s filtration system to complete final excretion. Individuals with moderate fatty liver or impaired liver function usually have serum alanine aminotransferase (ALT) or aspartate aminotransferase (AST) readings above the normal upper limit of 40 U/L. The additional lipid emulsification will force the liver to overwork.

• Blood indicators: triglycerides increase by 10% to 15% in concentration 7 days after injection
• Metabolic cycle: lipid clearance time for liver-damaged individuals extends from 28 days to 45 days
• Accumulation risk: unmetabolized lipids may form secondary deposits within liver lobules

Patients with severe kidney disease have an estimated glomerular filtration rate (eGFR) below 60 mL/min/1.73m². The damaged excretory pathway cannot effectively excrete dissolved metabolic waste along with the basic 2.5 liters of water intake within a 4-week cycle, and the local tissue edema period will extend from 14 days to more than 21 days. The phosphatidylcholine (PPC) in the preparation, with a purity of 99.8%, is derived from non-GMO soybean extract. Individuals with a history of immune rejection to soy protein have specific IgE antibodies, and contact with the stock solution will trigger an extremely strong histamine release reaction within 15 to 30 minutes.

Anaphylactic shock typically causes a sudden drop in blood pressure within 10 minutes of injecting the first 10ml of liquid.

Giant urticaria exceeding the grid area by 5 to 10 cm will appear at the injection site. Respiratory tract mucosa quickly develops edema under the action of histamine, and the airway diameter narrows by 30% to 50% within 5 minutes, accompanied by a rapid breathing rate of more than 25 times per minute. Individuals with autoimmune diseases such as Hashimoto’s thyroiditis or systemic lupus erythematosus have a confused macrophage recognition mechanism. The local aseptic inflammation caused by deoxycholic acid (DC) injected subcutaneously is misinterpreted by the immune system as a large-scale invasion of external pathogens.

• Fever reaction: body temperature soars above 38.5°C within 12 hours
• Uncontrolled inflammation: erythema that should subside within 14 days persists for more than 30 days
• Cellular attack: active white blood cells may attack normal dermal fibroblasts

The grid injection standard requires 20 to 30 high-frequency punctures in an area of 10cm x 15cm. A 30G with an outer diameter of 0.31mm will cut many branches of the subcutaneous arterial plexus when entering a depth of 13mm. Individuals with normal clotting function can achieve spontaneous hemostasis within 3 to 5 minutes. Patients taking anticoagulants such as aspirin, warfarin, or clopidogrel long-term usually have their prothrombin time international normalized ratio (INR) deliberately maintained between 2.0 and 3.0. Reduced platelet aggregation capacity prevents rapid formation of thrombus after microvessel rupture.

Discontinue blood-thinning medications for at least 7 to 10 days to allow platelet function to return to a safe baseline of 150,000/mcL.

If injections are performed without discontinuing medication, the subcutaneous bleeding from a single puncture can expand from a normal 0.1ml to 0.5ml or even 1.0ml. Blood diffusely permeates between fat lobules, forming a deep purple hematoma exceeding 50 square centimeters within 48 hours, with an absorption period of 6 to 8 weeks. During pregnancy and lactation, the exchange of nutrients between the maternal blood and the fetus or infant is highly active and shared. Deoxycholic acid (DC), with its extremely small molecular weight, can penetrate the placental barrier unimpeded and enter the fetal amniotic fluid and circulatory system. Large doses of free fatty acids can also enter the mammary ducts through the lipid metabolic network. The foreign chemical components and high concentrations of triglycerides mixed in breast milk can place 3 to 5 times the additional burden on the infant’s developing liver and kidney excretory systems. For the target injection area, the epidermis must maintain 100% integrity. Skin tissue with active psoriasis plaques, eczema lesions, or herpes simplex virus infection has a Staphylococcus aureus density of millions per square centimeter on its surface.

• Bacterial load: the number of miscellaneous bacteria on damaged epidermis is more than 10 times that of healthy skin
• Infection probability: the chance of the tip introducing surface bacteria to a depth of 13mm increases by 60%
• Complication evolution: subcutaneous infection can develop into deep purulent cellulitis within 72 hours

Postoperative Metabolic Management

After free fatty acids and triglycerides are phagocytosed by micro-macrophages, they form chylomicrons with a diameter of 0.5μm to 1.0μm. Chylomicrons rely on the physical flushing of lymph fluid to enter the microlymphatic capillary network. To maintain the osmotic pressure of the lymphatic system, 2.5 to 3.0 liters of pure water must be consumed daily. Increased water intake increases the basal lymphatic return rate from 1.5 milliliters per minute at rest to 4.5 milliliters. If daily water intake is less than 1.5 liters, tissue fluid viscosity increases by 15%, and the free time for metabolic waste is extended by 7 to 10 days. Urination frequency changes significantly within the first 7 days after intervention. The usual daily urine output of 800 milliliters to 1000 milliliters increases to 1500 milliliters to 2000 milliliters with water supplementation. The visual appearance of urine presents a deeper amber color in the first 72 hours due to the precipitation of metabolic byproducts. Within 48 to 72 hours after injection, the acute inflammatory edema period, the epidermal temperature naturally rises by 1.2°C to 1.5°C. External temperature intervention greatly affects the physical contraction state of subcutaneous capillaries. Exposure to heat sources above 38°C causes vascular lumen expansion of 20% to 30%.

• Indoor air temperature: air conditioning set to a constant temperature range of 20°C to 22°C
• Rinse water temperature: skin contact water temperature controlled below 37°C, single rinse no more than 10 minutes
• Heat source avoidance: strictly prohibited from entering a dry sauna environment with temperatures up to 80°C within 72 hours
• Radiation protection: avoid exposing the epidermis to natural light with a UV index above 5

Capillary dilation causes water in the plasma to accelerate its penetration into the interstitial tissue at a rate of 5 milliliters per hour. The natural regression period of physical edema is thus prolonged from the standard 7 days to more than 14 days. Excessive local skin tension will be accompanied by persistent dull pain at a level of 4/10. Deoxycholic acid (DC) releases billions of lipid microparticles, increasing the liver’s daily metabolic workload by 15% to 20%. Within a complete 28-day cycle, chemicals that increase workload will cause competitive exclusion. Ethanol enters the bloodstream, preferentially occupying the liver’s alcohol dehydrogenase (ADH) and cytochrome P450 system. The β-oxidation process of free fatty acids is completely halted until the blood alcohol concentration drops to 0. Consuming 10 grams of pure alcohol (equivalent to 300 milliliters of regular beer) within 14 days after surgery leads to fatty acid retention in liver cells for up to 48 hours. Long-term retained lipid microparticles have a 5% chance of re-esterification, forming secondary fat accumulation in the original space 13mm under the skin. Daily sodium salt intake is strictly limited to less than 1500 milligrams. The enrichment of sodium ions in the extracellular fluid creates a strong osmotic pressure. For every 1 gram of excessive sodium intake, the total volume of extracellular fluid increases by 400 milliliters, physically offsetting the 1.5 cm circumference reduction brought about by 30ml of liquid. Intense skeletal muscle contraction produces strong mechanical compression, changing the spherical distribution structure of the liquid in the 6mm to 13mm subcutaneous fat layer. Within the first 48 hours, high-intensity aerobic exercise with a heart rate exceeding 140 beats/minute forces incompletely reacted liquid to physically shift along the superficial fascia.

• Initial restriction: walking speed for both legs within 3 kilometers per hour within the first 48 hours
• Aerobic intervention: from day 4, moderate-speed brisk walking with a heart rate maintained at 110 beats/minute is allowed
• Abdominal pressure control: squats or deadlifts and other movements that produce high intra-abdominal pressure are delayed until day 14
• Muscle extension: avoid extreme stretching of the injected anatomical area by more than 15 degrees for the first 7 days

The physical diffusion of the liquid to non-target anatomical areas reduces the local chemical concentration of 1000mg PPC, leading to a 30% decrease in local fat cell rupture rate. However, after 72 hours, mild lower limb skeletal muscle contraction acts as a pump, increasing the microscopic transport efficiency of lymphatic vessels by 15% to 20%. External physical pressure is differentiated into deep tissue compression and uniform pressure on the epidermis. Within the first 72 hours of tissue biochemical repair, vertical finger pressure massage exceeding 5 pounds disrupts the microscopic environment where macrophages are forming encirclements, leading to secondary microvascular rupture within 0.5 centimeters under the epidermis. After entering the peak immune clearance period on day 7, gentle lymphatic drainage massage (applying 1 to 2 ounces of translational thrust) becomes a physical intervention to accelerate tissue metabolism. The massage trajectory follows the unidirectional valve structure of the lymphatic vessels, advancing towards the axillary or inguinal lymph node nodes at a translational speed of 2 centimeters per second.

• Initial pressure prevention: wear loose cotton clothing for the first 3 days, leaving a 3 cm gap at the waist to prevent physical indentations
• Mid-term pressure: starting from day 8, wear a medical-grade shaping garment with a surface pressure value of 15-20 mmHg
• Pressure duration: the skin contact time of the shaping garment is limited to 10 to 12 hours per day
• Palpation assessment: on day 15, apply 0.5 pounds of vertical pressure with the finger pad to check the softening rate of subcutaneous induration

Continuous uniform pressure (15-20 mmHg) physically reduces the cavity gap between the dermal layer and the muscle fascia layer. The subcutaneous space, cleared of 3 to 5 millimeters of fat lobules, is aided by constant pressure to stimulate fibroblasts to secrete type I collagen, completing tissue tightening on day 28.

Results Guide

Clinical observations show that within 72 hours, it belongs to the fat rupture period of PPC action, and tissue volume increases by 15-20% due to inflammatory edema. The fat excretion period begins on days 14-21, and ultrasound measurements show an average reduction of 2-3 millimeters in subcutaneous fat layer thickness. After the complete course of treatment (3-5 injections at 15-day intervals), at week 8, the circumference of large areas such as the abdomen or thighs can decrease by 1.5-3 inches, and the volume of free fat in facial areas such as the double chin can decrease by approximately 20-30%.

Phased Metabolic Time

Deoxycholic acid (DCA), upon contact with subcutaneous tissue, destroys the approximately 5-nanometer thick fat cell bilayer membrane within seconds. Cell membrane rupture leads to the leakage of internal triglycerides and free fatty acids into the interstitial space, completing preliminary physical dissolution. The human immune system initiates an aseptic inflammatory response within the first 72 hours after injection, with local capillaries dilating to deliver white blood cells. The skin surface temperature in the injection area usually rises by 0.5 to 1.0 degrees Celsius. Tissue fluid infiltrates the cell gaps, causing the expected edema. Using calipers, the physical thickness of the injection site typically increases by 15% to 20% on day 3 compared to before injection. To present changes in physical parameters more clearly, referring to European dermatology medical data, the clinical measurements throughout the observation period are as follows:

On day 4, macrophages gathered locally begin to clear broken organelles and lipid droplets. PPC (phosphatidylcholine) molecules act as emulsifiers, chemically breaking down large triglyceride molecules. The decomposed lipids become water-soluble microparticles with a diameter of less than 100 nanometers, preventing fatty acids from recrystallizing in situ. Visually, the originally red and swollen skin begins to fade, and the VAS pain score drops from the initial 4/10 to below 1/10. Touching around the injection site, a slight induration or hardening of the tissue can be felt. The fibrotic reaction indicates that macrophages are working intensively and usually softens naturally around day 14, restoring the original touch. Micro-emulsified lipid components need to be transported across regions via the lymphatic vessel network. Lymph fluid flow rate is usually only 1 to 2 ml/min, relying entirely on skeletal muscle contraction and tissue pressure differences for propulsion. From day 15 to 28, lipid microparticles pass through the thoracic duct into the subclavian vein, entering the bloodstream. The liver is responsible for receiving lipids from the blood and sending them into the mitochondria of liver cells. Through the β-oxidation pathway, triglycerides are metabolized into ATP (adenosine triphosphate), carbon dioxide, and water. Maintaining a daily water intake of 2.5 liters can increase the fat excretion efficiency of the urinary system in a resting state by approximately 12%. To match the transport load of lymphatic vessels, the American Society of Plastic Surgeons (ASPS) recommends that clinical intervention follow specific physical parameters:

• Minimum interval between two injections is 14 days
• Maximum total injection volume per site is 50ml
• Minimum horizontal spacing between puncture points is 1.5cm
• Puncture vertical depth maintained at 6-13mm
• Dosage per injection controlled at 0.2-0.5ml

Beginning in week 5, the absolute number of fat cells has decreased, and the tissue enters a remodeling phase. Fibroblasts, stimulated by PPC residues, begin to synthesize type I and type III collagen. High-frequency ultrasound imaging shows that the subcutaneous tissue, originally creating gaps due to cell rupture, begins to densify. The dermal layer thickness increases by an average of 10-15%, preventing skin laxity after local fat loss. Subjects who completed 3 abdominal injections (30ml each, 15 days apart) showed an average circumference reduction of 3.8 to 5.0 centimeters when measured with a soft ruler at the navel level at week 8. By week 12, the half-life of LIPOLAB has completely ended, and there is no longer any spontaneous biochemical dissolution activity locally. The volume reduction rate of the free fat pad in the submandibular area can reach 25% under magnetic resonance imaging (MRI). The basal metabolic rate (BMR) of an individual determines a slight shift in the above timeline. An adult with a BMR of 1800 kcal completes systemic lipid circulation approximately 4 to 6 days faster than someone with a BMR of 1400 kcal. Aerobic exercise on an elliptical machine, maintaining a heart rate of 110-130bpm for 150 minutes per week, can increase the microcirculation speed of peripheral blood by 20%. Daily calorie intake below consumption by 200-300 calories can promote the liver to prioritize processing free fatty acids transported from the injection site. Avoid consuming high glycemic index (GI>70) carbohydrates to prevent unruptured fat cells from compensatory volume expansion.

Differences in Efficacy by Body Part

The diffusion radius of 50 to 70 nanometer PPC particles in LIPOLAB is constrained by the anatomical structure of fatty tissue. The superficial and deep fat layers (SAT and DAT) of the face, limbs, and trunk exhibit clear physical differences in blood perfusion rates and extracellular matrix density. High-frequency ultrasound probe measurement data indicate that the distribution density of the subcutaneous capillary network influences the peak action time of deoxycholic acid (DCA). Areas with denser blood vessels have higher biochemical transport efficiency of free fatty acids into lymphatic vessels. The subcutaneous fat thickness in the submandibular area (double chin) is usually between 4 and 10 millimeters. The fat lobules in this area are enveloped by dense fibrous septa, and branches of the external jugular vein provide a blood flow of up to 15 to 20 ml/min/100 grams of tissue. Facial puncture depth must be strictly controlled at 6 to 8 millimeters to avoid touching the mandibular nerve branches.